Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Inex files to begin pivotal trial of Onco TCS

Oct. 6, 1999

Encouraging survival data reported for Genta's G-3139 in malignant melanoma trial

Oct. 6, 1999

Scotia seeks approval of Foscan in Europe

Oct. 5, 1999

Plant-produced antiangiogenic compound discovered by Phytera

Oct. 5, 1999

Scotia seeks FDA approval for Foscan PDT

Oct. 4, 1999

Genzyme Molecular Oncology licenses antisense cancer rights to Hybridon

Oct. 4, 1999

Cancer patients being enrolled at UNC for new trial evaluating third-generation SERM

Oct. 1, 1999

Pharma Mar presents phase I findings for ecteinascidin 743 at scientific forum

Oct. 1, 1999

Cell Genesys enters cancer gene therapy collaboration with Rigel

Oct. 1, 1999

Texas A&M describes important new class of agents for breast cancer

Sep. 30, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...
Recombinant vaccine inhibits HBV-associated HCC growth
BioWorld Science
Chronic liver disease and hepatocellular carcinoma (HCC) associated with chronic hepatitis B virus (HBV) are serious health problems in highly endemic areas....